BioMeta (Shanghai) Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 150

Employees

  • Latest Deal Type
  • Series A1

  • Investors
  • 4

BioMeta (Shanghai) General Information

Description

Developer of preclinical drugs designed for the biomedical industry. The company offers preclinical drug discovery, target verification, protein production, antibody production, in vitro drug testing, and cell level testing, enabling pharmaceutical companies and biotech startups to advance from concept to clinical readiness.

Contact Information

Website
www.biometas.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Building 5
  • Number 334 Edison Road, China Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2nd Floor, Building 5
  • Number 334 Edison Road, China Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMeta (Shanghai) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A1) 20-Jan-2026 Completed Generating Revenue
1. Early Stage VC 18-Sep-2024 Completed Generating Revenue
To view BioMeta (Shanghai)’s complete valuation and funding history, request access »

BioMeta (Shanghai) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMeta (Shanghai) Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adtech Advanced Technologies Corporation Minority
Hefei Industry Investment Group Venture Capital Minority
Huagai Capital Venture Capital Minority
PharmaResources Corporation Minority
To view BioMeta (Shanghai)’s complete investors history, request access »

BioMeta (Shanghai) Investments & Acquisitions (2)

BioMeta (Shanghai)’s most recent deal was a Later Stage VC with Drug Farm for . The deal was made on 13-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Drug Farm 13-Jul-2026 Later Stage VC Drug Discovery
ZSHK Lab 14-Apr-2026 Merger/Acquisition Laboratory Services (Healthcare)
To view BioMeta (Shanghai)’s complete investments and acquisitions history, request access »

BioMeta (Shanghai) Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
ZSHK Lab Hong Kong, Hong Kong 2019

BioMeta (Shanghai) FAQs

  • When was BioMeta (Shanghai) founded?

    BioMeta (Shanghai) was founded in 2022.

  • Where is BioMeta (Shanghai) headquartered?

    BioMeta (Shanghai) is headquartered in Shanghai, China.

  • What is the size of BioMeta (Shanghai)?

    BioMeta (Shanghai) has 150 total employees.

  • What industry is BioMeta (Shanghai) in?

    BioMeta (Shanghai)’s primary industry is Drug Discovery.

  • Is BioMeta (Shanghai) a private or public company?

    BioMeta (Shanghai) is a Private company.

  • What is BioMeta (Shanghai)’s current revenue?

    The current revenue for BioMeta (Shanghai) is .

  • Who are BioMeta (Shanghai)’s investors?

    Adtech Advanced Technologies, Hefei Industry Investment Group, Huagai Capital, and PharmaResources have invested in BioMeta (Shanghai).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process